Ultragenyx Pharmaceutical
RARE
RARE
274 hedge funds and large institutions have $3.63B invested in Ultragenyx Pharmaceutical in 2024 Q2 according to their latest regulatory filings, with 47 funds opening new positions, 117 increasing their positions, 80 reducing their positions, and 39 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
2% more funds holding
Funds holding: 268 → 274 (+6)
0.33% more ownership
Funds ownership: 97.06% → 97.4% (+0.33%)
3% less capital invested
Capital invested by funds: $3.73B → $3.63B (-$103M)
Holders
274
Holding in Top 10
6
Calls
$22.7M
Puts
$15M
Top Buyers
| 1 | +$69.5M | |
| 2 | +$61.5M | |
| 3 | +$47M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$44.4M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
+$40.1M |
Top Sellers
| 1 | -$157M | |
| 2 | -$23.7M | |
| 3 | -$19.7M | |
| 4 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
-$16.8M |
| 5 |
Mirae Asset Global Investments
Seoul,
South Korea
|
-$9.46M |